Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox vs Steroid Injections for Carpal Tunnel Syndrome
NCT00701233Phase 2Withdrawn
- Sponsor
- University of Minnesota
- Start
- Jun 2012
- Primary completion
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in carpal tunnel syndrome (CTS), sponsored by University of Minnesota. Planned start Jun 2012; status: withdrawn.
02
Drugs
botulinum toxin type A
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT00701233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00701233.